Carboplatin/Durvalumab/Etoposide Regimen

Preferred Label : Carboplatin/Durvalumab/Etoposide Regimen;

NCIt synonyms : Carboplatin/Durvalumab/Etoposide; Carboplatin-Durvalumab-Etoposide; Carboplatin-Durvalumab-Etoposide Regimen; Carboplatin/Imfinzi/Etoposide; Carboplatin-Imfinzi-Etoposide; Durvalumab/Carboplatin/Etoposide;

NCIt related terms : Carboplatin and Etoposide (CE) and Durvalumab;

NCIt definition : A regimen containing carboplatin, durvalumab and etoposide that can be used for the first-line treatment of extensive-stage small cell lung cancer (ES-SCLC) and cervical cancer.;

NCI Metathesaurus CUI : CL1405424;

Codes from synonyms : 49859;

Détails

Origin ID

C171041;

UMLS CUI

C5418971;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Carboplatin [NCIt concept]
- Durvalumab [NCIt concept]
- Etoposide [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients